Cargando…
1410. Novel Framework to Compare the Effectiveness of Tazobactam, Relebactam and Avibactam Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
BACKGROUND: Resistance mediated by extended-spectrum β-lactamases (ESBLs) presents a serious challenge in the treatment of Gram-negative pathogens. ESBLs confer resistance to most β-lactams which may be reversed with the addition of an active β-lactamase inhibitor (such as tazobactam, relebactam and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254093/ http://dx.doi.org/10.1093/ofid/ofy210.1241 |